David W. Hockenbrocht, Chairman
President & CEO
Sparton Corporation
James J. Barry, Ph.D.
VP Corporate Research & Advanced Technology Development
Boston Scientific
David S. Block, M.D., M.B.A.
Founder and CEO
Ruxton Pharmaceuticals, Inc.
David S. Bredt, M.D., Ph.D.
Vice President, Integrative Biology
Lilly Research Laboratories
James Campbell, M.D.
Scientific Advisor
Interwest Partners
C. Thomas Caskey, M.D., FACP
Director & CEO
Brown Foundation Institute of Molecular Medicine
Executive Vice President of Molecular Medicine and Genetics
The University of Texas Health Science Center at Houston
Joseph A. Ciffolillo
(retired medical device executive)
Kenneth Fasman, Ph.D.
(formerly with AstraZeneca PLC )
Philip Goelet, Ph.D.
Director
Red Abbey
Ms. Elizabeth Good
Director, Strategic Investments
University of Maryland at Baltimore
Steve Gorlin
Principal
Gorlin Companies
Leroy E. Hood, M.D., Ph.D.
President
Institute for Systems Biology
Edwin M. Kania, Jr.
Managing Partner and Chairman
Flagship Ventures | Robert S. King
Five Prime Advisors, LLC. Chris Kroeger, M.D., M.B.A.
Principal
--Aurora Funds, Inc.
Joseph Lawler, M.D., Ph.D.
Oz-Ziff Capital Management Group
Robert D. Mashal, M.D.
President & CEO
Alinea Pharmaceuticals
Troy Moore
Chief Technology Officer
Open Biosystems
Richard Newman
Vice President, Advanced Solutions
Welch Allyn, Inc.
James Niedel, M.D., Ph.D.
Managing Director
New Leaf Venture Partners, LLC
Stephen N. Oesterle, M.D.
Sr. Vice President for Medicine and Technology
Medtronic, Inc.
Mark C. Rogers, M.D., M.B.A.
Chairman and CEO
Bradmer Pharmaceuticals
Christopher Shen, M.D., M.B.A.
Partner
Essex Woodlands Health Ventures
Irving Sherman, M.D.
(retired neurosurgeon)
Amita Shukla
Principal
NEA
Craig R. Smith, M.D.
Williston Consulting, LLC
(retired Chairman, President, & CEO, Guilford Pharmaceuticals)
Joseph M. Smith, M.D., Ph.D., FACC
(formerly with Guidant Corporation) |
